DT-2216 is under clinical development by Dialectic Therapeutics and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success ...

(212a6) 35 Also, this definition admits of relevant refinements by means of further explanatory ... One may object that in I.11 77a26-35 Aristotle links dialectic and common principles. However, upon ...